Cargando…
A Small Molecule Agonist THIQ as a Novel Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants
Although mutations in the melanocortin-4 receptor (MC4R) gene cause severe early-onset obesity, we still do not have effective approaches to correct the defects of these mutations. Several antagonists have been identified as pharmacoperones of the MC4R whereas no agonist of the MC4R has been reporte...
Autores principales: | Huang, Hui, Tao, Ya-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115193/ https://www.ncbi.nlm.nih.gov/pubmed/25076858 http://dx.doi.org/10.7150/ijbs.9625 |
Ejemplares similares
-
Ipsen 5i is a Novel Potent Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants
por: Tao, Ya-Xiong, et al.
Publicado: (2014) -
Pharmacoperone Identification for Therapeutic Rescue of Misfolded Mutant Proteins
por: Conn, P. Michael, et al.
Publicado: (2011) -
Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias
por: Janovick, Jo Ann, et al.
Publicado: (2017) -
Therapeutic Rescue of Misfolded Mutants: Validation of Primary High Throughput Screens for Identification of Pharmacoperone Drugs
por: Janovick, Jo Ann, et al.
Publicado: (2011) -
OR0302 Regulation Of Human Melanocortin-5 Receptor By Isoforms Of Melanocortin-2 Receptor Accessory Proteins
por: Jiang, Shanshan, et al.
Publicado: (2023)